| editorial | Q871232 |
| scholarly article | Q13442814 |
| P50 | author | Vladimir Brusic | Q87201751 |
| Gavin C. Cawley | Q100222755 | ||
| Claus Lundegaard | Q110207431 | ||
| Włodzisław Duch | Q9382910 | ||
| Oliver Kohlbacher | Q29998906 | ||
| James E. Crowe, Jr. | Q37366747 | ||
| Morten Nielsen | Q37828921 | ||
| Tomer Hertz | Q41047529 | ||
| Hifzur Rahman Ansari | Q42883568 | ||
| Harris Papadopoulos | Q56480618 | ||
| Christos Panayiotou | Q56480619 | ||
| Ole Lund | Q59198225 | ||
| P2093 | author name string | Yohan Kim | |
| G P S Raghava | |||
| Guang Lan Zhang | |||
| Shanfeng Zhu | |||
| Michael T Rock | |||
| Xihao Hu | |||
| Craig A Magaret | |||
| Nebojsa Jojic | |||
| Li C Xue | |||
| Phil Bradley | |||
| Chen Yanover | |||
| Marios M Polycarpou | |||
| Vider-Shalit Tal | |||
| P433 | issue | 1-2 | |
| P921 | main subject | immunology | Q101929 |
| machine learning | Q2539 | ||
| P304 | page(s) | 1-4 | |
| P577 | publication date | 2011-09-29 | |
| P1433 | published in | Journal of Immunological Methods | Q15755939 |
| P1476 | title | Machine learning competition in immunology - Prediction of HLA class I binding peptides. | |
| P478 | volume | 374 |
| Q35984163 | A computational method for designing diverse linear epitopes including citrullinated peptides with desired binding affinities to intravenous immunoglobulin. |
| Q35872252 | A computational method for identification of vaccine targets from protein regions of conserved human leukocyte antigen binding |
| Q45003975 | A guide to in silico vaccine discovery for eukaryotic pathogens |
| Q38603909 | An Update on the Role of Immunotherapy and Vaccine Strategies for Primary Brain Tumors |
| Q39243052 | Antigen Discovery and Therapeutic Targeting in Hematologic Malignancies |
| Q35785418 | Automated benchmarking of peptide-MHC class I binding predictions |
| Q38262688 | Bioinformatics for cancer immunotherapy target discovery |
| Q44396424 | Bioinformatics identification of antigenic peptide: predicting the specificity of major MHC class I and II pathway players |
| Q42097385 | BlockLogo: visualization of peptide and sequence motif conservation |
| Q39092611 | Coevolution of Leukemia and Host Immune Cells in Chronic Lymphocytic Leukemia |
| Q39005162 | Comparison of experimental fine-mapping to in silico prediction results of HIV-1 epitopes reveals ongoing need for mapping experiments |
| Q34345342 | Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach. |
| Q40086895 | Dana-Farber repository for machine learning in immunology |
| Q33953557 | Dataset size and composition impact the reliability of performance benchmarks for peptide-MHC binding predictions |
| Q39945813 | Getting personal with neoantigen-based therapeutic cancer vaccines |
| Q38217357 | HLA-binding properties of tumor neoepitopes in humans |
| Q36088427 | Immune epitope database analysis resource |
| Q26866513 | Immunotherapy advances for glioblastoma |
| Q28069873 | Immunotherapy for Gastroesophageal Cancer |
| Q38842511 | Immunotherapy for oesophagogastric cancer |
| Q41771171 | In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census |
| Q42409414 | InCoB2012 Conference: from biological data to knowledge to technological breakthroughs |
| Q42729706 | MULTIPRED2: a computational system for large-scale identification of peptides predicted to bind to HLA supertypes and alleles |
| Q30002365 | Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation |
| Q37139374 | Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients |
| Q30008748 | NNAlign: a platform to construct and evaluate artificial neural network models of receptor-ligand interactions. |
| Q33785947 | PSSMHCpan: a novel PSSM-based software for predicting class I peptide-HLA binding affinity |
| Q93052152 | Pediatric patients with acute lymphoblastic leukemia generate abundant and functional neoantigen-specific CD8+ T cell responses |
| Q35012688 | PolyCTLDesigner: a computational tool for constructing polyepitope T-cell antigens |
| Q35813585 | Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy? |
| Q98771735 | Progress in Neoantigen Targeted Cancer Immunotherapies |
| Q33917224 | Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia |
| Q58587953 | Systematically benchmarking peptide-MHC binding predictors: From synthetic to naturally processed epitopes |
| Q38372371 | TANTIGEN: a comprehensive database of tumor T cell antigens |
| Q36316627 | Targeting the undruggable: immunotherapy meets personalized oncology in the genomic era. |
| Q36553815 | The Length Distribution of Class I-Restricted T Cell Epitopes Is Determined by Both Peptide Supply and MHC Allele-Specific Binding Preference |
| Q90481320 | The role of proteomics in the age of immunotherapies |
Search more.